Equities

Oxford Biodynamics PLC

OBD:LSE

Oxford Biodynamics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.280
  • Today's Change-0.02 / -6.67%
  • Shares traded19.11m
  • 1 Year change-46.67%
  • Beta2.8692
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Oxford Biodynamics PLC grew revenues 72.17% from 636.00k to 1.10m while net income improved from a loss of 11.57m to a smaller loss of 11.15m.
Gross margin47.67%
Net profit margin-1,018.54%
Operating margin-1,011.32%
Return on assets-110.46%
Return on equity-407.49%
Return on investment-148.46%
More ▼

Cash flow in GBPView more

In 2025, cash reserves at Oxford Biodynamics PLC fell by 435.00k. Cash Flow from Financing totalled 6.33m or 577.63% of revenues. In addition the company used 7.57m for operations while cash from investing totalled 813.00k.
Cash flow per share-0.0072
Price/Cash flow per share--
Book value per share0.0006
Tangible book value per share0.00001
More ▼

Balance sheet in GBPView more

Oxford Biodynamics PLC has a Debt to Total Capital ratio of 82.08%, a lower figure than the previous year's 107.71%.
Current ratio0.8753
Quick ratio0.8005
Total debt/total equity4.58
Total debt/total capital0.8208
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.